0
Seattle Genetics Banner Image

Seattle Genetics

  • Ticker SGEN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Seattle Genetics Logo Image
  • 501-1000 Employees
  • Based in Bothell, Washington
Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States.
REPORT RATINGS
5.0 / 5.0 (1)

Seattle Genetics reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Seattle Genetics

Most Recent Responsibility Report

Seattle Genetics
MOST RECENT 2022 Corporate Responsibility Report

Seattle Genetics does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived Seattle Genetics Sustainability Report, Seattle Genetics Corporate Social Responsibility Report, Seattle Genetics CSR Report, Seattle Genetics Corporate Responsibility, Seattle Genetics CR Report, Seattle Genetics Citizenship Report, Seattle Genetics ESG Report, and Seattle Genetics Environmental Report online.
Seattle Genetics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!